News Breaks |
|
|
| December 10, 2012 |
| 16:16 EDT |  | GILD | Gilead board approves 2-for-1 stock split
Gilead Sciences announced that its board of directors has approved a two-for-one stock split of the company's outstanding common stock to be effected through a stock dividend. Stockholders of record as of the close of business on January 7, 2013 will be entitled to a stock dividend of one additional share of common stock for every share of common stock they own. The company's stock will begin trading at the post-split price on January 28, 2013. |
|
|
News For GILD From The Last 14 Days Check below for free stories on GILD the last two weeks. |
|
|
| May 21, 2013 |
| 16:51 EDT | | GILD | Gilead's sofosbuvir gets EMA validation, now under assessment
 Subscribe for More Information |
|
| May 20, 2013 |
| 07:34 EDT |  | GILD | UBS to host a conference
Subscribe for More Information |
|
| May 16, 2013 |
| 11:50 EDT | | GILD | Celgene, Gilead lower after new data published at ASCO
Subscribe for More Information |
|
| May 15, 2013 |
| 18:32 EDT | | GILD | Gilead announces response data from Phase 2 study of Idelalisib
Subscribe for More Information |
|
| May 13, 2013 |
| 09:39 EDT |  | GILD | Active equity option families trading
Active equity option families trading on open according to Track Data: AAPL C TSLA LVS GILD FSLR |
|
|
|
|
|
